The Double-Edged Sword of Metabolic and Bariatric Surgery: Extending the Biliary Limb Can Trigger Bacterial Translocation, Sepsis, and Liver Inflammation – An Experimental Study

Dear Editor, We read with great interest the recent experimental study by Louis et al published in the International Journal of Surgery, which systematically examined the impact of biliary limb length in one-anastomosis gastric bypass (OAGB) and identified microbiota-associated liver injury as a major driver of early mortality in an extreme bypass model[1]. The authors are to be commended for integrating surgical anatomy, microbiological analyses, and survival outcomes in a coherent experimental framework, and for demonstrating that antibiotic-based gut decontamination markedly improves short-term survival. This manuscript complies with the TITAN Guidelines 2025. No artificial intelligence tools were used in the preparation or writing of this Letter[2]. From mechanistic clarity to translational uncertainty While the proposed causal pathway – extreme biliary limb length leading to bacterial overgrowth, translocation, endotoxemia, and liver injury – is biologically plausible and well supported by the presented data, we believe an important conceptual distinction warrants further discussion. Specifically, it remains unclear whether the observed survival benefit of antibiotics reflects selective interruption of bacterial translocation, or whether antimicrobial treatment functions more broadly as a multidimensional buffer against converging postoperative risks[3,4]. Antibiotics as a systemic risk modifier In the present study, antibiotics were initiated 1 week prior to surgery and continued throughout the postoperative period. This design effectively demonstrates that preemptive suppression of microbial burden can prevent early mortality in animals exposed to extreme anatomical perturbation. However, antibiotic intervention in this context likely influences multiple biological dimensions beyond bacterial translocation alone. These include attenuation of overall microbial metabolic activity, reduction of pathogen-associated molecular patterns, modulation of bile acid–microbiota interactions, and dampening of systemic inflammatory tone[5–7]. Consequently, the antibiotic-associated survival benefit may reflect mitigation of a complex postoperative stress milieu, rather than correction of a single dominant pathogenic pathway. Prevention versus rescue: a critical translational gap From a clinical standpoint, this distinction is highly relevant. Patients undergoing OAGB are not routinely managed with prolonged preoperative gut decontamination, nor is broad-spectrum antibiotic prophylaxis feasible or desirable for all individuals at theoretical risk. Instead, clinicians most often encounter patients who develop early postoperative liver dysfunction, sepsis-like features, or unexplained deterioration days to weeks after surgery. In such scenarios, antibiotics – if used – serve as rescue therapy, not prophylaxis. The current data therefore leave unanswered whether antibiotic therapy initiated after the emergence of liver injury or systemic inflammation would confer comparable benefit, or whether its efficacy depends on preemptive suppression of multiple early insults. Implications for future research Disentangling these possibilities will be critical for clinical translation. Delayed-intervention models, biomarker-guided rescue strategies, or more targeted microbial modulation approaches may help clarify whether bacterial translocation is the dominant driver or one component of a broader failure cascade. Such clarification would not diminish the importance of the authors’ findings, but rather strengthen their translational impact by aligning mechanistic insight with clinically actionable decision frameworks.